Williams Natalie M, Morrison Brian W
Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
Skin Appendage Disord. 2021 Jan;7(1):62-65. doi: 10.1159/000511470. Epub 2020 Nov 10.
Subungual pyogenic granuloma (PG) can be caused by numerous medications including chemotherapeutic agents. These lesions grow rapidly, oftentimes causing significant pain and bleeding, prompting patients to seek treatment. The management of subungual PG ranges from topical steroids to surgical excision. However, patients with chemotherapy-induced PGs are prone to developing multiple or recurrent lesions. Therefore, finding a therapeutic option that effectively eliminates the tumor and prevents the need for repeated procedural interventions is important. The use of topical β-adrenergic antagonists has been reported to be effective in regressing cutaneous PG.
In this report, we present a case of chemotherapy-induced subungual PG of the toenail arising in a 62-year-old woman that was successfully treated with topical timolol solution.
This case highlights the promising use of timolol solution for therapeutically challenging PGs, such as those of subungual regions. This option may be particularly useful for individuals who are vulnerable to multiple PGs secondary to chemotherapy who wish to avoid repeated procedural interventions.
甲下化脓性肉芽肿(PG)可由多种药物引起,包括化疗药物。这些病变生长迅速,常常引起明显疼痛和出血,促使患者寻求治疗。甲下PG的治疗方法从局部使用类固醇到手术切除不等。然而,化疗诱导的PG患者容易出现多个或复发性病变。因此,找到一种能有效消除肿瘤并避免重复进行手术干预的治疗选择很重要。据报道,局部使用β-肾上腺素能拮抗剂可有效使皮肤PG消退。
在本报告中,我们介绍了一名62岁女性发生的化疗诱导的趾甲甲下PG病例,该病例成功地用噻吗洛尔溶液局部治疗。
本病例突出了噻吗洛尔溶液在治疗具有挑战性的PG(如甲下区域的PG)方面的潜在用途。对于那些因化疗易患多个PG且希望避免重复手术干预的个体,该选择可能特别有用。